Literature DB >> 7658

Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment.

D Pericić, J R Walters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 7658     DOI： 10.1111/j.2042-7158.1976.tb02784.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  5 in total

Review 1.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

3.  Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems.

Authors:  J Cott; J Engel
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

4.  Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.

Authors:  S M Wuerthele; N M Friedle; K E Moore
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

5.  The effect of intraperitoneal injection of GABA or GHBA on monoamine histofluorescence in the rat brain.

Authors:  M Smiałowska; E Slusarska
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.